US Patent

US11564934 — Stable corticosteroid compositions

Method of Use · Assigned to Viropharma Biologies LLC · Expires 2039-01-10 · 13y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects pharmaceutical compositions containing a corticosteroid and an antioxidant for treating or alleviating gastrointestinal tract inflammation.

USPTO Abstract

The invention relates to pharmaceutical compositions comprising a corticosteroid and an antioxidant. The invention further relates to methods of treating, preventing, or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract comprising administering the pharmaceutical compositions comprising a corticosteroid and an antioxidant.

Drugs covered by this patent

Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3820`	—	Pulmicort Respules

Patent Metadata

Patent number: US11564934
Jurisdiction: US
Classification: Method of Use
Expires: 2039-01-10
Drug substance claim: No
Drug product claim: No
Assignee: Viropharma Biologies LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.